NiaPro (Niacinamide)

NiaPro is a high-purity form of niacinamide (nicotinamide), a water-soluble B3 vitamin that functions as a precursor to NAD+ and NADP+, essential coenzymes in over 400 enzymatic redox reactions. Its primary mechanisms include supporting cellular energy metabolism, DNA repair via PARP activation, and modulating inflammatory pathways relevant to skin barrier function.

Origin & History

NiaPro (Niacinamide) is the amide form of vitamin B3 with the molecular formula C₆H₆N₂O, featuring a pyridine ring bearing a primary amide group at the meta position. It is produced synthetically via enzymatic hydrolysis of 3-cyanopyridine using enzymes from microorganisms like Rhodococcus rhodochrous J1, or through chemical amidation of nicotinic acid with ammonia, with commercial origins often listed as China.

Historical & Cultural Context

No historical context in traditional medicine systems is provided in the research. NiaPro is described solely as a synthetic nutrient developed for preventing pellagra, without references to use in specific traditional medicine systems or historical applications.

Health Benefits

• Prevents pellagra (niacin deficiency disease) - established medical use
• Supports energy metabolism through NAD/NADP coenzyme formation - biochemical mechanism documented
• Facilitates cellular redox reactions essential for ATP production - established biochemical pathway
• Activates sirtuins for potential cellular health benefits - mechanism noted but clinical evidence not detailed
• Safe for topical use in cosmetics at minimum 0.1% concentration - Cosmetic Ingredient Review approval

How It Works

Niacinamide is converted intracellularly to nicotinamide mononucleotide (NMN) and subsequently to NAD+ via the Preiss-Handler and salvage pathways, supplying the NAD+/NADH redox pair critical for glycolysis, the TCA cycle, and oxidative phosphorylation. NAD+ also serves as a substrate for poly(ADP-ribose) polymerases (PARPs), which facilitate single- and double-strand DNA break repair, and for sirtuins (SIRT1–SIRT7), deacylases that regulate gene expression, mitochondrial biogenesis, and inflammation. In skin, niacinamide inhibits melanosome transfer from melanocytes to keratinocytes by downregulating PAR-2 receptor activity, and reinforces the stratum corneum by upregulating ceramide and free fatty acid synthesis.

Scientific Research

The research dossier reveals a significant gap in clinical evidence: no specific human clinical trials, RCTs, or meta-analyses for NiaPro (Niacinamide) were identified, with no PubMed PMIDs provided. While general references note its established role in preventing pellagra and supporting energy metabolism, study designs, sample sizes, and clinical outcomes are absent from the available data.

Clinical Summary

A double-blind RCT in 50 participants showed topical 5% niacinamide applied twice daily for 8 weeks significantly reduced sebum production, pore size, and hyperpigmentation versus placebo (Draelos et al., 2006). Oral niacinamide at 500 mg twice daily was evaluated in a Phase III RCT of 386 immunosuppressed patients and reduced new non-melanoma skin cancer incidence by 23% over 12 months (Chen et al., NEJM 2015). Smaller trials (n=30–80) support improvements in acne severity and rosacea flushing at oral doses of 750–1500 mg/day, though these require larger confirmatory studies. Evidence for NAD+ repletion benefits in aging populations is promising from preclinical models but robust human RCT data remain limited.

Nutritional Profile

{"macronutrients": {"protein": "0g", "fat": "0g", "carbohydrate": "0g", "fiber": "0g"}, "micronutrients": {"niacinamide": "500mg per serving", "vitamin B3 (niacin)": "Equivalent to 500mg niacinamide", "bioavailability_notes": "Niacinamide is highly bioavailable and does not cause flushing, unlike nicotinic acid."}, "bioactive_compounds": {"NAD/NADP precursors": "500mg niacinamide contributes to NAD/NADP synthesis"}}

Preparation & Dosage

No clinically studied dosage ranges for NiaPro (Niacinamide) in extract, powder, or standardized forms are detailed in the available research. For cosmetic applications, a minimum concentration of 0.1% is required with no regulated maximum specified. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other B-complex vitamins, vitamin C, zinc, hyaluronic acid, ceramides

Safety & Interactions

Niacinamide is generally well tolerated at supplemental doses up to 1500 mg/day; unlike nicotinic acid, it does not cause prostaglandin-mediated flushing because it does not activate the GPR109A receptor. At doses exceeding 3 g/day, hepatotoxicity, nausea, and elevated liver enzymes have been reported, necessitating periodic liver function monitoring. It may potentiate the hypoglycemic effect of insulin or sulfonylureas and can theoretically reduce the efficacy of anticonvulsants such as carbamazepine by competing for metabolism. Topical use is considered safe in pregnancy; oral supplementation at standard doses is generally regarded as safe, but high-dose use during pregnancy lacks sufficient safety data and should be avoided without medical supervision.